CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.

Handel Lexicon - LXRX CFD

2.51
7.72%
  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.05
Long position, gebyr natten over

Long position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
-0.025457%
Short position, gebyr natten over

Short position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
0.003235%
Gebyr natten over, tid 21:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Lexicon Pharmaceuticals Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

Nøglestatistikker
Tidligere luk* 2.72
Åben* 2.67
1-Års Ændring* 50%
Dagens Spænd* 2.44 - 2.67
52-Ugers Spænd 1.31-3.79
Gennemsnitlig Volumen (10 dage) 5.05M
Gennemsnitlig Volumen (3 måneder) 29.81M
Market Cap 520.35M
P/E-forhold -100.00K
Udestående aktier 244.85M
Omsætning 126.00K
EPS -0.63
Dividend (Udbytte %) N/A
Beta 1.27
Næste indtjeningsopgørelse Jul 31, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Jun 2, 2023 2.72 -0.03 -1.09% 2.75 2.77 2.64
Jun 1, 2023 2.68 0.00 0.00% 2.68 2.70 2.54
May 31, 2023 3.27 0.39 13.54% 2.88 3.39 2.87
May 30, 2023 2.86 -0.52 -15.38% 3.38 3.43 2.65
May 26, 2023 3.14 0.12 3.97% 3.02 3.20 2.90
May 25, 2023 2.86 -0.17 -5.61% 3.03 3.03 2.83
May 24, 2023 2.98 -0.04 -1.32% 3.02 3.02 2.94
May 23, 2023 3.02 -0.16 -5.03% 3.18 3.27 3.02
May 22, 2023 3.17 0.10 3.26% 3.07 3.27 3.03
May 19, 2023 2.97 0.04 1.37% 2.93 3.00 2.86
May 18, 2023 2.86 -0.04 -1.38% 2.90 2.91 2.76
May 17, 2023 2.89 -0.04 -1.37% 2.93 2.94 2.84
May 16, 2023 2.90 -0.03 -1.02% 2.93 2.95 2.81
May 15, 2023 2.94 0.06 2.08% 2.88 3.01 2.84
May 12, 2023 2.83 -0.29 -9.29% 3.12 3.16 2.81
May 11, 2023 3.10 0.06 1.97% 3.04 3.17 2.98
May 10, 2023 3.03 -0.13 -4.11% 3.16 3.16 2.91
May 9, 2023 3.00 -0.24 -7.41% 3.24 3.24 2.96
May 8, 2023 3.23 -0.27 -7.71% 3.50 3.53 3.20
May 5, 2023 3.45 0.36 11.65% 3.09 3.75 3.05

Lexicon Events

Tid (UTC) (UTC) Land Begivenhed
Monday, July 31, 2023

Tid (UTC) (UTC)

10:59

Land

US

Begivenhed

Q2 2023 Lexicon Pharmaceuticals Inc Earnings Release
Q2 2023 Lexicon Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Tuesday, November 7, 2023

Tid (UTC) (UTC)

10:59

Land

US

Begivenhed

Q3 2023 Lexicon Pharmaceuticals Inc Earnings Release
Q3 2023 Lexicon Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Se alle begivenheder
  • Årlig
  • Pr kvartal
2022 2021 2020 2019 2018
Total omsætning 0.139 0.298 23.995 322.073 63.209
Omsætning 0.139 0.298 23.995 322.073 63.209
Kost af omsætning, Total 0 0 1.929 3.231 2.491
Bruttofortjeneste 0.139 0.298 22.066 318.842 60.718
Totale Driftsudgifter 100.899 87.388 70.792 180.628 166.488
Salgs/Generelle/Admin. Udgifter, Total 48.083 32.342 47.23 56.835 63.754
Forskning & Udvikling 52.816 55.046 153.621 91.924 100.243
Other Operating Expenses, Total 0 0
Driftsindtægter -100.76 -87.09 -46.797 141.445 -103.279
Renteindkomst (Udgift), Netto Ikke-Drift -2.78 -0.802 -14.544 -20.676 -20.777
Andre, Netto 1.596 0.134 2.767 3.35 3.508
Netto Indkomst Før Skat -101.944 -87.758 -58.574 124.119 -120.548
Netto Indkomst Efter Skat -101.944 -87.758 -58.574 130.133 -120.548
Netto Indkomst Før Ekstra Ting -101.944 -87.758 -58.574 130.133 -120.548
Netto Indkomst -101.944 -87.758 -58.574 130.133 -120.548
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -101.944 -87.758 -58.574 130.133 -120.548
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -101.944 -87.758 -58.574 130.133 -120.548
Fortyndet Netto Indkomst -101.944 -87.758 -58.574 130.133 -120.548
Fortyndet Vægtet Gennemsnit Aktier 165.733 145.652 110.841 116.747 105.83
Fortyndet EPS Uden Ekstraordinære Ting -0.61511 -0.60252 -0.52845 1.11466 -1.13907
Fortyndet Normaliseret EPS -0.61511 -0.60252 -1.71924 1.2741 -1.13907
Totale Ekstraordinære Ting 0
Usædvanlig Udgift (Indkomst) 0 0 -131.988 28.638
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total omsætning 0.024 0.028 0.039 0.035 0.037
Omsætning 0.024 0.028 0.039 0.035 0.037
Kost af omsætning, Total
Bruttofortjeneste
Totale Driftsudgifter 31.166 30.306 23.134 24.042 23.417
Salgs/Generelle/Admin. Udgifter, Total 19.14 16.329 12.577 10.686 8.491
Forskning & Udvikling 12.026 13.977 10.557 13.356 14.926
Driftsindtægter -31.142 -30.278 -23.095 -24.007 -23.38
Renteindkomst (Udgift), Netto Ikke-Drift -1.821 -1.103 -0.864 -0.703 -0.11
Andre, Netto 1.029 0.887 0.572 0.123 0.014
Netto Indkomst Før Skat -31.934 -30.494 -23.387 -24.587 -23.476
Netto Indkomst Efter Skat -31.934 -30.494 -23.387 -24.587 -23.476
Netto Indkomst Før Ekstra Ting -31.934 -30.494 -23.387 -24.587 -23.476
Netto Indkomst -31.934 -30.494 -23.387 -24.587 -23.476
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -31.934 -30.494 -23.387 -24.587 -23.476
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -31.934 -30.494 -23.387 -24.587 -23.476
Fortyndet Netto Indkomst -31.934 -30.494 -23.387 -24.587 -23.476
Fortyndet Vægtet Gennemsnit Aktier 189.014 188.98 174.904 149.616 149.15
Fortyndet EPS Uden Ekstraordinære Ting -0.16895 -0.16136 -0.13371 -0.16433 -0.1574
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Fortyndet Normaliseret EPS -0.16895 -0.16136 -0.13371 -0.16433 -0.1574
Usædvanlig Udgift (Indkomst) 0
  • Årlig
  • Pr kvartal
2022 2021 2020 2019 2018
Totale Nuværende Aktiver 140.866 88.921 157.719 337.754 173.324
Likvider og Kortsigtede Investeringer 138.357 86.743 152.275 271.659 160.052
Likvider & Lignende 46.345 64.065 126.263 36.112 80.386
Kortsigtede Investeringer 92.012 22.678 26.012 235.547 79.666
Totale Tilgodehavender, Netto 0.028 0.014 0.395 56.532 5.924
Accounts Receivable - Trade, Net 0.028 0.014 0.395 56.532 5.924
Prepaid Expenses 2.481 2.164 5.049 5.32 2.668
Total Assets 194.299 136.909 203.788 417.715 284.136
Property/Plant/Equipment, Total - Net 4.371 3.476 1.495 15.747 15.865
Property/Plant/Equipment, Total - Gross 8.355 8.329 7.31 77.488 75.871
Accumulated Depreciation, Total -3.984 -4.853 -5.815 -61.741 -60.006
Goodwill, Net 44.543 44.543 44.543 44.543 44.543
Intangibles, Net 0 19.716 50.119
Other Long Term Assets, Total 4.519 -0.031 0.031 -0.045 0.285
Total Current Liabilities 23.172 22.124 46.806 65.341 36.751
Accounts Payable 10.395 9.152 5.469 12.178 17.759
Accrued Expenses 12.373 10.469 29.691 42.151 14.482
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 11.646 11.012 1.115
Other Current Liabilities, Total 0.404 2.503 0 3.395
Total Liabilities 77.175 23.314 47.417 300.614 310.541
Total Long Term Debt 48.579 0 0 234.171 243.887
Long Term Debt 48.579 0 234.171 243.887
Deferred Income Tax 0 6.014
Other Liabilities, Total 5.424 1.19 0.611 1.102 23.889
Total Equity 117.124 113.595 156.371 117.101 -26.405
Common Stock 0.189 0.15 0.142 0.106 0.106
Additional Paid-In Capital 1709.14 1608.75 1561.1 1462.17 1447.95
Retained Earnings (Accumulated Deficit) -1589.72 -1487.78 -1400.02 -1341.44 -1471.58
Treasury Stock - Common -2.061 -7.518 -4.843 -3.817 -2.876
Other Equity, Total -0.428 -0.01 -0.006 0.084 -0.012
Total Liabilities & Shareholders’ Equity 194.299 136.909 203.788 417.715 284.136
Total Common Shares Outstanding 188.726 148.917 141.496 106.272 105.926
Total Inventory 0 4.243 4.68
Redeemable Preferred Stock 0 0 0 0 0
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Totale Nuværende Aktiver 109.546 140.866 139.063 64.898 88.431
Likvider og Kortsigtede Investeringer 105.937 138.357 136.203 61.968 86.502
Likvider & Lignende 26.001 46.345 18.834 21.45 59.52
Kortsigtede Investeringer 79.936 92.012 117.369 40.518 26.982
Totale Tilgodehavender, Netto 0.261 0.028 0.039 0.034 0.037
Accounts Receivable - Trade, Net 0.261 0.028 0.039 0.034 0.037
Prepaid Expenses 3.348 2.481 2.821 2.896 1.892
Total Assets 162.716 194.299 191.685 112.325 136.178
Property/Plant/Equipment, Total - Net 8.627 4.371 8.032 2.835 3.242
Property/Plant/Equipment, Total - Gross 6.303 8.355 6.109 6.105 6.104
Accumulated Depreciation, Total -4.096 -3.984 -5.177 -5.07 -4.962
Goodwill, Net 44.543 44.543 44.543 44.543 44.543
Other Long Term Assets, Total 4.519 0.047 0.049 -0.038
Total Current Liabilities 20.371 23.172 18.445 16.862 18.905
Accounts Payable 10.311 10.395 9.427 7.347 9.321
Accrued Expenses 9.576 12.373 8.299 9.038 8.864
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases
Total Liabilities 74.67 77.175 47.667 41.495 43.48
Total Long Term Debt 48.845 48.579 23.784 23.631 23.477
Other Liabilities, Total 5.454 5.424 5.438 1.002 1.098
Total Equity 88.046 117.124 144.018 70.83 92.698
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.19 0.189 0.189 0.15 0.15
Additional Paid-In Capital 1712.56 1709.14 1705.61 1608.73 1605.9
Retained Earnings (Accumulated Deficit) -1621.65 -1589.72 -1559.23 -1535.84 -1511.25
Treasury Stock - Common -2.885 -2.061 -2.061 -2.061 -2.061
Other Equity, Total -0.163 -0.428 -0.491 -0.15 -0.037
Total Liabilities & Shareholders’ Equity 162.716 194.299 191.685 112.325 136.178
Total Common Shares Outstanding 189.562 188.726 188.726 149.626 149.594
Other Current Liabilities, Total 0.484 0.404 0.719 0.477 0.72
Long Term Debt 48.845 48.579 23.784 23.631 23.477
  • Årlig
  • Pr kvartal
2022 2021 2020 2019 2018
Netto indkomst/Startlinje -101.944 -87.758 -58.574 130.133 -120.548
Likvider Fra Driftsaktiviteter -88.851 -87.017 -142.969 113.807 -148.607
Likvider Fra Driftsaktiviteter 0.427 0.292 2.934 3.654 3.683
Deferred Taxes 0 0 -6.014 0
Ikke-Likvide Ting 12.264 10.68 -118.408 44.321 13.032
Likvid Rente Betalt 2.289 0.799 17.353 19.211 16.465
Ændringer i Driftskapital 0.402 -10.231 31.079 -58.287 -44.774
Likvider fra Investeringsaktiviteter -71.078 2.11 380.756 -155.855 169.576
Kapitaludgifter -1.326 -1.221 -0.087 -0.07 -0.095
Andre Investerings-Cash-Flow-Ting, Total -69.752 3.331 380.843 -155.785 169.671
Likvider fra Financieringsaktiviteter 142.209 22.709 -147.636 -2.226 -2.244
Udstedelse (Pensionering) af Aktier, Netto 93.341 34.409 68.944 -0.941 -0.24
Udstedelse (Pensionering) af Gæld, Netto 48.868 -11.7 -216.58 -1.285 -2.004
Netto Ændring i Likviditet -17.72 -62.198 90.151 -44.274 18.725
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -31.934 -101.944 -71.45 -48.063 -23.476
Cash From Operating Activities -31.613 -88.851 -67.282 -47.843 -23.421
Cash From Operating Activities 0.112 0.427 0.324 0.216 0.109
Non-Cash Items 3.68 12.264 8.648 5.783 2.797
Cash Interest Paid 1.556 2.289 1.281 0.634 0.085
Changes in Working Capital -3.471 0.402 -4.804 -5.779 -2.851
Cash From Investing Activities 12.093 -71.078 -95.252 -18.056 -4.408
Capital Expenditures -0.248 -1.326 -0.08 -0.076 -0.076
Other Investing Cash Flow Items, Total 12.341 -69.752 -95.172 -17.98 -4.332
Cash From Financing Activities -0.824 142.209 117.303 23.284 23.284
Issuance (Retirement) of Stock, Net -0.824 93.341 93.404 -0.864 -0.864
Issuance (Retirement) of Debt, Net 0 48.868 23.899 24.148 24.148
Net Change in Cash -20.344 -17.72 -45.231 -42.615 -4.545
Deferred Taxes
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
Artal International S.C.A. Investment Advisor 45.506 86262020 0 2023-03-31 LOW
BVF Partners L.P. Hedge Fund 8.5192 16149179 0 2023-03-31 LOW
Ulys, L.L.C. Investment Advisor 2.7979 5303814 0 2022-08-01
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.792 5292626 43032 2023-03-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 2.7644 5240247 -11438 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.6709 5062976 -201281 2023-03-31 LOW
Invus Public Equities Advisors, LLC Investment Advisor 1.8549 3516214 0 2023-03-31 LOW
JP Morgan Asset Management Investment Advisor 1.6081 3048374 56229 2023-03-31 LOW
D. E. Shaw & Co., L.P. Hedge Fund 1.5515 2940997 -136976 2023-03-31 LOW
New Enterprise Associates (NEA) Venture Capital 1.2567 2382286 0 2023-03-31 LOW
Pinnacle Associates Ltd. Investment Advisor/Hedge Fund 1.0235 1940224 7447 2023-03-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9102 1725409 117468 2023-03-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.8251 1564098 47623 2023-03-31 LOW
Coats Lonnel Individual Investor 0.3927 744359 158356 2023-02-28 LOW
Fisher Investments Investment Advisor/Hedge Fund 0.38 720243 0 2023-03-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.3794 719182 306384 2023-03-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.3633 688611 -7329 2023-03-31 LOW
Parkman Healthcare Partners LLC Hedge Fund 0.3563 675328 254126 2023-03-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.3561 675018 -19915 2023-03-31 LOW
Asset Management One Co., Ltd. Investment Advisor/Hedge Fund 0.3194 605528 605528 2022-08-31 LOW

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group

535K+

Handlende

87K+

Månedlkige, aktive klienter

$113M+

Månedlig investeringsvolumen

$64M+

Hævet hver måned

Handelslommeregner

Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

Handelskurtage
0
  • 1:1
Gearing
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long

Lexicon Company profile

Om Lexicon

Lexicon Pharmaceuticals, Inc. er en biofarmaceutisk virksomhed. Virksomheden fokuserer på opdagelse, udvikling og markedsføring af farmaceutiske produkter til behandling af sygdomme hos mennesker. Virksomhedens pipeline omfatter Sotagliflozin, LX9211 og LX2761. Sotagliflozin er et lille molekylært stof til oral indgivelse, som er under udvikling til behandling af hjertesvigt og type I-diabetes samt type II-diabetes, hjertesvigt og kronisk nyresygdom. LX9211 er et lille molekylært stof, der gives oralt, og som er under udvikling til behandling af neuropatiske smerter. Selskabet gennemfører et klinisk fase II-forsøg med LX9211 til behandling af diabetiske perifere neuropatiske smerter og et andet klinisk fase II-forsøg med LX9211 til behandling af postherpetisk neuralgi. LX2761 er et lille molekylært stof til oral indgivelse, der er designet til at hæmme natrium-glukose cotransporter 1 (SGLT1) lokalt i mave-tarmkanalen uden nogen hæmning af natrium-glukose cotransporter 2 (SGLT2) i nyrerne.

Industry: Bio Therapeutic Drugs

8800 Technology Forest Place
8800 Technology Forest Place
77381

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

US100

14,542.90 Price
-0.100% 1D Chg, %
Long position, gebyr natten over -0.0255%
Short position, gebyr natten over 0.0032%
Gebyr natten over, tid 21:00 (UTC)
Spænd 1.8

Oil - Crude

72.00 Price
0.000% 1D Chg, %
Long position, gebyr natten over -0.0149%
Short position, gebyr natten over -0.0070%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.03

BTC/USD

25,820.95 Price
-5.490% 1D Chg, %
Long position, gebyr natten over -0.0616%
Short position, gebyr natten over 0.0137%
Gebyr natten over, tid 21:00 (UTC)
Spænd 60.00

Gold

1,962.62 Price
+0.700% 1D Chg, %
Long position, gebyr natten over -0.0184%
Short position, gebyr natten over 0.0102%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.30

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 535.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel